AI summary · may contain errors
Multimodal composite scoring detected ctDNA in 70% of CSF versus 17% of plasma samples from 28 pediatric CNS tumor patients, outperforming any single modality alone.
- Open access
Moving in Leukemia, Journal of Clinical Oncology, JNCI: Journal of the National Cancer Institute, Journal for ImmunoTherapy of Cancer, The Lancet Child & Adolescent Health, The Lancet Haematology, bioRxiv and Blood.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Multimodal composite scoring detected ctDNA in 70% of CSF versus 17% of plasma samples from 28 pediatric CNS tumor patients, outperforming any single modality alone.
AI summary · may contain errors
BCL-2 family prosurvival proteins act as tumor suppressors in thymic cell-competition models, where Bcl2 loss or modest MCL-1/BCL-XL reduction accelerates T-ALL-like leukemia.
AI summary · may contain errors
Triple therapy with dexamethasone, ABT-199, and the N-cadherin antagonist ADH-1 kills acute lymphoblastic leukaemia (ALL) cells in high-risk patient-derived xenograft-ALL samples.
AI summary · may contain errors
In two patient-derived B-cell acute lymphoblastic leukemia cases, clonal barcoding and multiome single-cell profiling show unidirectional differentiation from an immature source cluster into differentiated progeny.
AI summary · may contain errors
OTTER, an optimal-transport multi-omics deep learning framework, significantly outperforms state-of-the-art methods for T-lineage acute lymphoblastic leukemia subtyping in the COG AALL0434 cohort of >1,300 patients across 17 subtypes.
AI summary · may contain errors
Childhood cancers are frequently linked to inherited genetic predisposition, and close surveillance in children with cancer predisposition syndromes improves survival and reduces therapy-related toxicity.
AI summary · may contain errors
In 347 patients with Ewing sarcoma across Euro Ewing 2012 (EE2012) phase II/III, ctDNA-detected TP53/STAG2 loss-of-function or CDKN2A focal deletions defined a molecular high-risk subgroup with worse survival (EFS HR 3.6, OS HR 4.3).
AI summary · may contain errors
In 56 acute myeloid leukemia patients, AML-CAPP-Seq plasma ctDNA enabled universal MRD assessment with a median of 30.5 tracked variants per patient.
AI summary · may contain errors
Baseline FDG PET/CT detected non-central nervous system extramedullary disease in 44% of 16 adults and children with relapsed/refractory B-ALL.
AI summary · may contain errors
In 79 pediatric and young adult patients with relapsed/refractory B-cell ALL, 5-year relapse-free survival among responders was 47.3% (or 51.0% with different censoring), with no new safety signals.
AI summary · may contain errors
Adding decitabine to busulfan-cyclophosphamide conditioning before allogeneic HSCT reduces 2-year relapse incidence in adults with KMT2A-rearranged leukaemia from 29% to 12%.
AI summary · may contain errors
In the DCCSS-LATER cohort of 10,612 Dutch childhood cancer 5-year survivors, SMN risk declined over diagnosis periods, but chemotherapy shifts—especially anthracyclines/epipodophyllotoxins—were linked to higher risk.
AI summary · may contain errors
mTORC1 inhibition upregulates CD20 and enhances anti-CD20 monoclonal antibody efficacy in B-cell precursor acute lymphoblastic leukemia, including models with IKZF1 deletions.
AI summary · may contain errors
GradientScreen, a microfluidic ratiometric combination drug screening assay for high-risk paediatric acute lymphoblastic leukaemia, links drug response metrics to clinical outcomes, including MRD.
AI summary · may contain errors
LIN28B is essential for normal human fetal liver CD34+ cells to sustain proliferation and stem-like traits, and it is required for KMT2A::AFF1 iALL transformation.
AI summary · may contain errors
In KMT2A-rearranged B-cell acute lymphoblastic leukemia, the ITGA4–NG2 axis is linked to Rho GTPase activity and leukemic aggressiveness, and natalizumab delays progression in xenografts.
AI summary · may contain errors
PTEN-loss in T-cell acute lymphoblastic leukemia creates dependence on IMPDH, and IMPDH inhibition selectively kills PTEN-deficient cells in mouse genetic and xenograft models.
Journals this month
Topics moving, week to 17 Nov 2026
By field